These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18627530)

  • 21. Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
    Buscà R; Berra E; Gaggioli C; Khaled M; Bille K; Marchetti B; Thyss R; Fitsialos G; Larribère L; Bertolotto C; Virolle T; Barbry P; Pouysségur J; Ponzio G; Ballotti R
    J Cell Biol; 2005 Jul; 170(1):49-59. PubMed ID: 15983061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF.
    Borgdorff V; Rix U; Winter GE; Gridling M; Müller AC; Breitwieser FP; Wagner C; Colinge J; Bennett KL; Superti-Furga G; Wagner SN
    Oncogene; 2014 May; 33(19):2531-9. PubMed ID: 23728343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
    Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UCHL1 Regulates Melanogenesis through Controlling MITF Stability in Human Melanocytes.
    Seo EY; Jin SP; Sohn KC; Park CH; Lee DH; Chung JH
    J Invest Dermatol; 2017 Aug; 137(8):1757-1765. PubMed ID: 28392346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.
    Vlčková K; Vachtenheim J; Réda J; Horák P; Ondrušová L
    J Cell Mol Med; 2018 Apr; 22(4):2240-2251. PubMed ID: 29369499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.
    Wellbrock C; Arozarena I
    Pigment Cell Melanoma Res; 2015 Jul; 28(4):390-406. PubMed ID: 25818589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.
    Swoboda A; Soukup R; Eckel O; Kinslechner K; Wingelhofer B; Schörghofer D; Sternberg C; Pham HTT; Vallianou M; Horvath J; Stoiber D; Kenner L; Larue L; Poli V; Beermann F; Yokota T; Kubicek S; Krausgruber T; Rendeiro AF; Bock C; Zenz R; Kovacic B; Aberger F; Hengstschläger M; Petzelbauer P; Mikula M; Moriggl R
    Oncogene; 2021 Feb; 40(6):1091-1105. PubMed ID: 33323974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
    Du J; Miller AJ; Widlund HR; Horstmann MA; Ramaswamy S; Fisher DE
    Am J Pathol; 2003 Jul; 163(1):333-43. PubMed ID: 12819038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual roles of lineage restricted transcription factors: the case of MITF in melanocytes.
    Levy C; Fisher DE
    Transcription; 2011; 2(1):19-22. PubMed ID: 21326905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
    Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
    Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem Cell Factor-Inducible MITF-M Expression in Therapeutics for Acquired Skin Hyperpigmentation.
    Yun CY; Roh E; Kim SH; Han J; Lee J; Jung DE; Kim GH; Jung SH; Cho WJ; Han SB; Kim Y
    Theranostics; 2020; 10(1):340-352. PubMed ID: 31903124
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipocalin-type prostaglandin D synthase as a melanocyte marker regulated by MITF.
    Takeda K; Yokoyama S; Aburatani H; Masuda T; Han F; Yoshizawa M; Yamaki N; Yamamoto H; Eguchi N; Urade Y; Shibahara S
    Biochem Biophys Res Commun; 2006 Jan; 339(4):1098-106. PubMed ID: 16337607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
    Wellbrock C; Marais R
    J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epigenetic regulation of gene expression in malignant melanoma].
    Laurette P; Koludrovic D; Coassolo S; Davidson I
    Biol Aujourdhui; 2016; 210(4):283-295. PubMed ID: 28327285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells.
    Poindexter KM; Matthew S; Aronchik I; Firestone GL
    Cell Biol Toxicol; 2016 Apr; 32(2):103-19. PubMed ID: 27055402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.
    Pathria G; Garg B; Borgdorff V; Garg K; Wagner C; Superti-Furga G; Wagner SN
    Cell Death Dis; 2016 Mar; 7(3):e2135. PubMed ID: 26962685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JNK suppresses melanogenesis by interfering with CREB-regulated transcription coactivator 3-dependent MITF expression.
    Kim JH; Hong AR; Kim YH; Yoo H; Kang SW; Chang SE; Song Y
    Theranostics; 2020; 10(9):4017-4029. PubMed ID: 32226536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation.
    Kido K; Sumimoto H; Asada S; Okada SM; Yaguchi T; Kawamura N; Miyagishi M; Saida T; Kawakami Y
    Cancer Sci; 2009 Oct; 100(10):1863-9. PubMed ID: 19659611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism.
    Allouche J; Rachmin I; Adhikari K; Pardo LM; Lee JH; McConnell AM; Kato S; Fan S; Kawakami A; Suita Y; Wakamatsu K; Igras V; Zhang J; Navarro PP; Lugo CM; Noonan HR; Christie KA; Itin K; Mujahid N; Lo JA; Won CH; Evans CL; Weng QY; Wang H; Osseiran S; Lovas A; Németh I; Cozzio A; Navarini AA; Hsiao JJ; Nguyen N; Kemény LV; Iliopoulos O; Berking C; Ruzicka T; Gonzalez-José R; Bortolini MC; Canizales-Quinteros S; Acuna-Alonso V; Gallo C; Poletti G; Bedoya G; Rothhammer F; Ito S; Schiaffino MV; Chao LH; Kleinstiver BP; Tishkoff S; Zon LI; Nijsten T; Ruiz-Linares A; Fisher DE; Roider E
    Cell; 2021 Aug; 184(16):4268-4283.e20. PubMed ID: 34233163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.
    Eliades P; Abraham BJ; Ji Z; Miller DM; Christensen CL; Kwiatkowski N; Kumar R; Njauw CN; Taylor M; Miao B; Zhang T; Wong KK; Gray NS; Young RA; Tsao H
    J Invest Dermatol; 2018 Jul; 138(7):1582-1590. PubMed ID: 29408204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.